MEDICAPS

MediCaps Share Price

₹51.23 +0.16 (0.31%)

22 Jan, 2025 16:13

SIP TrendupStart SIP in MEDICAPS

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume

Investment Returns

  • Over 1 Month + 2.46%
  • Over 3 Month -5.55%
  • Over 6 Month + 2.09%
  • Over 1 Year -6.58%
SIP Lightning

Smart Investing Starts Here Start SIP with MediCaps for Steady Growth!

Invest Now

MediCaps Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -43
  • PEG Ratio
  • -1.7
  • Market Cap Cr
  • 64
  • P/B Ratio
  • 0.5
  • Average True Range
  • 3.54
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.09
  • RSI
  • 50.99
  • MFI
  • 87.63

MediCaps Financials

MediCaps Technicals

EMA & SMA

Current Price
₹51.23
+ 0.16 (0.31%)
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 0
  • 20 Day
  • ₹50.73
  • 50 Day
  • ₹50.94
  • 100 Day
  • ₹50.92
  • 200 Day
  • ₹50.20

Resistance and Support

51.59 Pivot Speed
  • R3 59.26
  • R2 56.88
  • R1 53.97
  • S1 48.68
  • S2 46.30
  • S3 43.39

What's your outlook on MediCaps?

You can only vote for once

MediCaps Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-12 Quarterly Results
2024-08-07 Quarterly Results
2024-05-23 Quarterly Results
2024-02-08 Quarterly Results
2023-11-08 Quarterly Results

MediCaps F&O

MediCaps Shareholding Pattern

No data available.

About MediCaps

  • NSE Symbol
  • MEDICAPS
  • BSE Symbol
  • 523144
  • ISIN
  • INE442D01010

Similar Stocks to MediCaps

MediCaps FAQs

MediCaps share price is ₹51 As on 22 January, 2025 | 15:59

The Market Cap of MediCaps is ₹63.9 Cr As on 22 January, 2025 | 15:59

The P/E ratio of MediCaps is -43 As on 22 January, 2025 | 15:59

The PB ratio of MediCaps is 0.5 As on 22 January, 2025 | 15:59

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23